Publications by authors named "Dubravka Pelicaric"
Nintedanib treatment for bleomycin-induced lung injury - First report.
Respir Med Case Rep
September 2023
Article Synopsis
- Bleomycin, an antineoplastic agent used for over 50 years, poses significant pulmonary toxicity risks, potentially affecting 10% of patients.
- The exact mechanisms behind its pharmacological effects and side effects remain unclear, complicating treatment.
- A case report highlights a successful use of nintedanib for a patient with bleomycin-induced lung injury, emphasizing the need for more research and clinical trials in managing these toxicities.
Bronchodilator response in patients with persistent allergic asthma could not predict airway hyperresponsiveness.
Allergy Asthma Clin Immunol
December 2007
: Anticholinergics, or specific antimuscarinic agents, by inhibition of muscarinic receptors cause bronchodilatation, which might correlate with activation of these receptors by the muscarinic agonist methacholine. The aim of this study was to determine whether a positive bronchodilator response to the anticholinergic ipratropium bromide could predict airway hyperresponsiveness in patients with persistent allergic asthma. The study comprised 40 patients with mild and moderate persistent allergic asthma.
View Article and Find Full Text PDF